HOUSTON SCHOONMAKER: Open Payments
NPI 1962096115 · MERKEL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 15 payments from 7 companies in 2025. Trend: 2023 $224 · 2024 $362 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $345 |
| ABIOMED | 1 | $136 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Viatris Specialty LLC | 1 | $40 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: AIRSUPRA, BREZTRI, CAPLYTA, YUPELRI, Auvelity, Kerendia.
Industry payments across TX — which companies pay providers there.
